Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45810, first published .
Correction: Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

Correction: Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

Correction: Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

Jelena Maksimenko   1 , MD, PhD ;   Pedro Pereira Rodrigues   2 , MSc, PhD ;   Miki Nakazawa-Miklaševiča   3 , MSc, PhD ;   David Pinto   4 , MD ;   Edvins Miklaševičs   3 , Prof Dr biol ;   Genadijs Trofimovičs   5 , MD, PhD ;   Jānis Gardovskis   6 , MD, PhD ;   Fatima Cardoso   4 , MD ;   Maria João Cardoso   4 , MD, PhD

1 Institute of Oncology, Department of Surgery, Breast Unit, Pauls Stradiņš Clinical University Hospital, Riga Stradiņš University, Riga, Latvia

2 Information and Health Decision Sciences of the Faculty of Medicine, University of Porto, Porto, Portugal

3 Institute of Oncology, Riga Stradiņš University, Riga, Latvia

4 Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal

5 Faculty of Medicine, Rīga Stradiņš University, Riga, Latvia

6 Department of Surgery, Faculty of Medicine, Pauls Stradins Clinical University Hospital, Rīga Stradiņš University, Riga, Latvia

Corresponding Author:

  • Jelena Maksimenko, MD, PhD
  • Institute of Oncology, Department of Surgery, Breast Unit
  • Pauls Stradiņš Clinical University Hospital
  • Riga Stradiņš University
  • Dzirciema 16
  • Riga
  • Latvia
  • Phone: 371 27038577
  • Email: jelena.maksimenko@rsu.lv